A case control investigation of COVID-19 associated mucormycosis in India
Start at : November 16, 2022
Published In BMJ Infectious Disease
Increased occurrence of mucormycosis during the second wave of the COVID-19 pandemic in early 2021 in India prompted us to undertake a multi-site case–control investigation. The objectives were to examine the monthly trend of COVID-19 Associated Mucormycosis (CAM) cases among in-patients and to identify factors associated with the development of CAM